Astrocytes are known to facilitate repair following brain injury; however, little is known about how injured astrocytes repair themselves. Repair of cell membrane injury requires Ca 2+ -triggered vesicle exocytosis. In astrocytes, lysosomes are the main Ca 2+ -regulated exocytic vesicles. Here we show that astrocyte cell membrane injury results in a large and rapid calcium increase. This triggers robust lysosome exocytosis where the fusing lysosomes release all luminal contents and merge fully with the plasma membrane. In contrast to this, receptor stimulation produces a small sustained calcium increase, which is associated with partial release of the lysosomal luminal content, and the lysosome membrane does not merge into the plasma membrane. In most cells, lysosomes express the synaptotagmin (Syt) isoform Syt VII; however, this isoform is not present on astrocyte lysosomes and exogenous expression of Syt VII on lysosome inhibits their exocytosis. Deletion of one of the most abundant Syt isoform in astrocyte -Syt XI -suppresses astrocyte lysosome exocytosis. This identifies lysosome as Syt XI-regulated exocytic vesicle in astrocytes. Further, inhibition of lysosome exocytosis (by Syt XI depletion or Syt VII expression) prevents repair of injured astrocytes. These results identify the lysosomes and Syt XI as the sub-cellular and molecular regulators, respectively of astrocyte cell membrane repair.
Astrocyte secretion through membrane channels, 1 exocytosis of small synaptic-like vesicles (SSLV; 30-50 nm) [2] [3] [4] and large vesicles (4200 nm) 2, [5] [6] [7] regulate neuronal and vascular functions. [8] [9] [10] Lysosomes are large, and the major Ca 2+ -triggered exocytic vesicles in astrocytes. 11, 12 Whereas receptor signaling triggers lysosome exocytosis in astrocytes, in other cell types, cell membrane damage is a potent trigger of lysosome exocytosis. [13] [14] [15] [16] Lysosome exocytosis facilitates repair of injured cells, 14 and through secretion of adenosine triphosphate (ATP), cytokines and cytolytic proteins also facilitates repair of injured tissue. [17] [18] [19] Although the role of lysosomal exocytosis in ATP secretion by astrocytes has been documented, its role in astrocyte cell membrane repair has not been examined. 20, 21 Regulated exocytosis involves SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) and calcium-sensing protein Syt. SNAREs present on the opposing membranes interact with each other to assemble into a trans-SNARE complex. 22 Subsequently, calcium binding to the C2 domains of synaptotagmin triggers full trans-SNARE assembly, which provides the force needed for vesicle fusion. 23 About half of all Syt isoforms have been shown to be non-Ca 2+ binding and even the Ca 2+ -binding Syts are known to regulate Ca 2+ -independent steps such as vesicle docking at the target membrane. [24] [25] [26] Although Syt XI is among the most abundant Syt isoform in astrocytes, 27 Syt IVthe only Syt isoform studied in astrocytes -regulates SSLV exocytosis. 28 In other cells, lysosome exocytosis is regulated by Syt VII 15, 29 but there is conflicting evidence of Syt VII expression in astrocytes. 11, 20, 27, 28, 30 Thus, the synaptotagmin regulating lysosomal exocytosis in astrocytes is yet to be identified. Further, neuroglial signaling is the only role of Ca 2+ -triggered exocytosis in astrocytes that has been studied. [8] [9] [10] Using total internal reflection fluorescence (TIRF) microscopy here we have monitored receptor stimulation-triggered and cell membrane injury-triggered exocytosis of individual lysosome in astrocytes and studied its role in cell membrane repair. Injury caused a greater increase in intracellular calcium (cytosolic calcium, [Ca 2+ ] c ) than receptor stimulation, which affected the nature and kinetics of lysosome exocytosis. Receptor stimulation caused continued lysosomal fusions where lysosomes partially release their content (partial fusion). In contrast, injury caused a rapid burst of fusion events, and the fusing lysosomes fully released luminal and membrane content (complete fusion). Syt XI, but not Syt VII, was detected on astrocyte lysosomes. Depletion of Syt XI and expression of Syt VII on astrocyte lysosome reduced lysosome exocytosis, prevented full fusion of lysosomes, and compromised the ability of astrocytes to repair. This identifies cell membrane repair as a new role of lysosome exocytosis in (Figure 1a) , whereas metabotropic glutamate receptor signaling caused [Ca 2+ ] c to peak with a delay of 5s followed by continued oscillations (Figure 1b) . Direct Ca 2+ entry by focal cell membrane injury by a pulsed laser caused an instantaneous rise in [Ca 2+ ] c , which decreased over the next minute as the cell repaired ( Figure 1c) . 16 Calcium ionophore (ionomycin) caused rapid and sustained increase in [Ca 2+ ] c (Figure 1d ). The amplitude of [Ca 2+ ] c increase by injury or ionomycin was twice as large as the receptor-mediated signaling (Figure 1e) .
To examine the effect of differential [Ca 2+ ] c increase on lysosome exocytosis, individual lysosomes were imaged using TIRF microscopy. Fluorescently labeling lysosomes with fluorescein isothicyanate (FITC) dextran allows imaging without photodamage. 12 [Ca 2+ ] c increase by purinergic signaling triggered sustained FITC dextran-labeled lysosome exocytosis that peaked within a minute, and most fusions occurred within the first 90 s of ATP addition (Figure 1f ; Supplementary Video 1). Each cell exocytosed 10.5 ± 2.5 lysosomes in a minute ( Figure 1j) ; however, many membrane proximal lysosomes did not exocytose (Figure 1f , inset). Metabotropic signaling also caused sustained lysosomal exocytosis (Figure 1g ; Supplementary Video 1), with each cell exocytosing 14.0 ± 3.1 lysosome/minute; again all membrane proximal lysosomes did not exocytose (Figures 1j and g,  inset) . In contrast to receptor stimulation, direct increase in [Ca 2+ ] c by focal cell membrane injury caused the lysosome exocytosis to peak within 10 s. Half of all exocytic events occurred by 30 s and all fusions ceased by 140 s (Figure 1h ; Supplementary Video 1). Each cell exocytosed 26.9 ± 2.9 lysosomes/minute, and most of the membrane docked lysosomes underwent exocytosis (Figures 1j and h, inset) . Direct [Ca 2+ ] c increase by ionomycin caused half of all exocytic events to occur within the first 20 s (Figure 1i ; Supplementary Video 1). Each cell exocytosed an average of 27.7 ± 7.1 lysosomes/minute, and all lysosomes at the cell membrane underwent exocytosis within 100 s of treatment (Figures 1j and i, inset). Astrocytes derived from mice and rats exhibited similar exocytic response -ionomycin triggered 26.9 ± 2.9 versus 25.2 ± 6.9 exocytic events/minute, respectively. As an alternate assay for injury-triggered lysosomal exocytosis, astrocytes were injured with glass beads (in presence of TRITC dextran to mark injured cells) and cell surface appearance of lysosomal membrane protein (LAMP1) was monitored in live cells using an antibody that binds the luminal domain of LAMP1. 31 The cell surface LAMP1 level increased in all injured astrocytes, demonstrating injury-triggered lysosome exocytosis (Figures 2a and b) .
Lysosome exocytosis in astrocytes is regulated differently compared with that in fibroblasts. Similar to other vesicles, 32, 33 lysosomes can fuse partially, releasing a part of their luminal content, and their membrane does not merge with the plasma membrane. 29, 34 However, the existence of partial exocytosis of astrocyte lysosomes has been contested. 11, 20 Using FITC dextran to label the lysosome lumen, we found that astrocyte lysosomes can exocytose their contents partially (Figure 2c ) or fully (Figure 2d ). In fibroblasts, lysosomes that partially release their contents have a restricted fusion pore that allows the release of smaller (10 kDa), but not larger (500 kDa) sized dextran. 29 However, partially fusing astrocyte lysosomes released both small and large sized dextran (Figures 2e and g ), indicating that partially exocytosing lysosomes do not have the same restricted fusion pore as in fibroblasts. 29 Another feature of partially exocytosing fibroblast lysosomes is that the lysosomal membrane protein (for example, CD63-GFP) does not diffuse into the plasma membrane. 29 Using CD63-GFP labeling we observed threefold fewer ATP-triggered exocytic events/cell (3 ± 0.9; Figure 2f , green circles), as compared with the luminal marker FITC dextran (10.5 ± 2.5; Figure 1i ). This indicates that, similar to fibrobalsts, partially exocytosing astrocyte lysosomes do not release CD63-GFP into the plasma membrane. When [Ca 2+ ] c in the same cell was raised further by ionomycin treatment, many of the lysosomes that had not released CD63-GFP upon ATP treatment released all of their CD63-GFP (Figure 2f , red circles), indicating ionomycin-triggered complete exocytosis. An alternate possibility is that ionomycin caused lysis of the CD63-GFP- labeled lysosome. We have shown that monitoring CD63-GFP fluorescence by TIRF allows distinguishing between lysosome exocytosis and lysis. 12 As the CD63-GFP-labeled lysosome enters the TIRF field, there is a rapid increase in vesicle-associated fluorescence intensity ('peak intensity'). Exocytosis and lysis both decrease the peak fluorescence. 
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Lysis causes decrease through the loss of fluorophores into the cytoplasm, whereas exocytosis causes decrease by diffusion of the fluorophores into the plasma membrane. Thus, integrated TIRF fluorescence ('total intensity') in the cell membrane plane decreases during lysis but remains constant during exocytosis. 12, 35, 36 Upon ionomycin treatment, the 'total intensity' of lysosomal CD63-GFP increased and then remained constant ( Figure 2f inset and corresponding plot in Figure 2h ), demonstrating that CD63-GFP dispersed freely into the plasma membrane. This established that the lysosomes underwent exocytosis.
Next, we tested whether differential [Ca 2+ ] c increase affected partial or complete lysosome exocytosis. Receptormediated increase in [Ca 2+ ] c resulted in predominantly partial exocytosis 91 ± 3% (ATP) and 79 ± 4% (3,5-Dihydroxyphenylglycine, DHPG; Figures 2i and j), whereas injury and ionomycin caused predominantly complete exocytosis 63 ± 1% and 69 ± 3.9%, respectively (Figures 2k and l). This is unlike fibroblasts, where lysosomes undergo predominantly partial exocytosis independent of the means of [Ca 2+ ] c increase. 29 As ionomycin and injury cause greater [Ca 2+ ] c increase as compared with ATP and DHPG, it is possible that the amplitude of [Ca 2+ ] c increase regulates the nature of (partial/complete) lysosome exocytosis. Alternately, calcium entry by ATP and DHPG may be occuring through transporters not close enough to the lysosomes to trigger full release. 37 This could explain the release of CD63-GFP by more lysosomes following ionomycin as compared with ATP treatment (Figure 2f ). To examine the link between [Ca 2+ ] c and the nature of lysosome fusion, we next examined the involvement of synaptotagmin in this process.
Lack of Syt VII on astrocyte lysosomes facilitates Ca 2+ -triggered exocytosis. Synaptotagmin VII is known to regulate lysosomal exocytosis; 29, 38 however, Syt VII expression in astrocytes is disputed. 27, 28 Multiple Syt VII isoforms reported in neurons and chromaffin cells. 39, 40 Mouse myoblasts expressed two Syt VII isoforms (45 and 51 kDa), whereas mouse astrocytes showed very weak expression of the 51-kDa and none of the 45-kDa isoform (Figure 3a) . Whereas the 45-kDa isoform is known to localize on the vesicles, the 51-kDa isoform localizes to the cell membrane. 39, 40 To test whether the 51-kDa isoform localizes to astrocyte lysosomes, protein from the subcellular fractions of primary astrocytes were probed with anti-LAMP1 and antiSyt VII antibodies (Figure 3b ). The LAMP1-positive fractions (F1-F3) showed no Syt VII (Figure 3b ) and the fraction (F6) with the 51-kDa band was devoid of lysosomes. Immunostaining showed that Syt VII was mostly diffuse, and none of the punctate Syt VII labeling colocalized with the lysosomal marker LAMP1 (Figure 3c ). Thus, lysosomes in primary astrocytes do not express Syt VII. To test when expressed exogenously, can the 45-kDa isoform of Syt VII (Figure 3d ) traffic to the astrocyte lysosome, a GFP-tagged 45-kDa isoform was expressed, which localized to the lysosomes (Figure 3e ). This indicated that the absence of endogenous Syt VII on the astrocyte lysosomes is not due to the lack of proper trafficking machinery.
On the basis of our previous findings 29 that lysosomes in Syt VII knockout fibroblasts undergo complete fusion without restricted pore size, we hypothesized that lack of Syt VII on astrocyte lysosomes may be responsible for the similar nature of lysosomal exocytosis in astrocytes (Figures 2e and h ). If so, this would predict that expression of Syt VII on astrocyte lysosomes will cause reduced and predominantly partial exocytosis. Expression of Syt VII on the astrocyte lysosomes resulted in the following: (1) decreased injury-triggered lysosomal exocytosis -13.7 ± 3.3 compared with 29.2 ± 3.3 fusion/cell/min in control transfected cells ( Figure 3f) ; (2) increased proportion of lysosomes that underwent partial exocytosis ( Figure 3g) ; and (3) caused a twofold increase (20 s versus 10 s) in the time needed for half of injury-triggered lysosome exocytosis to occur (Figure 3h ). These observations establish that the lack of Syt VII on lysosomes facilitates rapid and complete exocytosis in astrocytes and suggests that another synaptotagmin isoform regulates Ca 2+ -dependent lysosome exocytosis in astrocytes.
Syt XI regulates lysosomal exocytosis in astrocytes.
To identify the synaptotagmin that regulates lysosome exocytosis in astrocytes, we examined the synaptotagmins IV, V and XI, which are known to be expressed in astrocytes. 28 Whereas all these synaptotagmins showed punctate expression, only Syt XI colocalized with lysosomes (Figures 4a and b) . Syt XI is the most abundant Syt isoform in astrocytes and is expressed more abundantly in the astrocytes as compared with the neurons; 27, 28, 30 however, its subcellular localization in astrocytes is not known. 41, 42 Use of western blot analysis confirmed expression of Syt XI protein in primary astrocytes (Figure 4c ). Using cell fractionation we found that endogenous Syt XI is enriched in the lysosome fractions (Figure 4d ), demonstrating its localization on astrocyte lysosomes.
Using siRNA-mediated knockdown we tested the role of Syt XI in lysosomal exocytosis in astrocytes. Four Syt XI-specific siRNAs were pooled together or used individually; each caused 490% decrease in Syt XI expression (Figure 4e ). Injury of Syt XI-depleted cells resulted in twofold increase in the number of partial lysosome exocytosis events (Figures 4f and k) and threefold decrease in the total number of lysosome exocytosis events/cell/min (Supplementary Figure 1A ; Figure 4j ). Depletion of Syt XI did not alter the kinetics of lysosomal exocytosis (Figure 4g ), suggesting that the low level (~10%) of Syt XI in the knockdown cells may be responsible for the residual lysosomal exocytosis. To establish the specificity of Syt XI knockdown effect, we generated Syt XI cDNA with conservative base substitutions that made this cDNA (SytXIr-GFP) refractory to one of the Syt XI siRNA -siRNA2. siRNA2 prevented expression of Syt XI-GFP, but not of SytXIr-GFP (Figures 4h and i) . SytXIr-GFP expression not only reversed the decrease in lysosome exocytosis caused by siRNA2-mediated Syt XI knockdown, it also reversed the decrease in the fraction of complete fusion (Figures 4j and k) . This established the requirement of Syt XI for Ca 2+ -dependent exocytosis of lysosomes in astrocytes.
Lysosomal exocytosis is required for the repair of injured astrocytes. Although astrocytes can repair injury to their cell membrane, 43 the mechanism for this has remained enigmatic. In other cells, lysosome exocytosis facilitates repair of injury to their cell membrane. 14, 16 However, in view of above differences in the nature and regulation of astrocyte lysosome exocytosis, we examined whether injury-triggered lysosome exocytosis still facilitates repair of injured astrocytes. Intact cells exclude the lipophilic dyes (FM1-43, FM4-64) from the cytosol; however, injury causes these dyes to enter the cell and bind endomembrane ( Supplementary  Videos 2) . 31 This causes continuous increase in cellular dye fluorescence until the cell membrane is repaired and dye entry is blocked. 31 Use of this approach established the obligate requirement of injury-triggered calcium entry for 
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Syt XI regulates repair of injured astrocytes SC Sreetama et al ( Figure 5b , blue curve). This provided the first evidence that inhibition of lysosome exocytosis (by Syt VII expression) inhibits cell membrane repair. However, as Syt VII is not normally expressed on astrocyte lysosomes, we next assessed astrocyte repair following inhibition of lysosome exocytosis by Syt XI knockdown. Depletion of Syt XI by a siRNA pool compromised the ability of astrocytes to repair (Figure 5c ) and caused extensive cytoplasmic labeling with FM1-43 dye (Figure 5d ; Supplementary Video 5). Repair was also compromised when Syt XI was depleted using siRNA2 ( Figure 5e , red curve), and was fully reversed by the expression of SytXIr-GFP ( Figure 5e , green curve; Figure 5f ). This established that injury-triggered lysosome exocytosis, mediated by Syt XI, is required for the repair of injury to the astrocyte plasma membrane. Next, we examined whether the Syt XI regulation of lysosome exocytosis in astrocytes involves the binding of Ca 2+ to the three aspartate residues present in the Syt XI C2B domain. SytXIr cDNA was mutated to replace Aspartates (D) with asparagines (N) to generate SytXIrDN-GFP (siRNA-resistant Syt XI cDNA with aspartate to aspargaine mutation-GFP; Supplementary  Figure 2 ). We hypothesized that if these aspartates coordinate the Ca 2+ ion in a manner similar to Syt IV, then Syt XIrDN will inhibit Ca 2+ -triggered lysosome exocytosis and impair the ability of the injured astrocytes to undergo repair. Using CD63 to mark late endosome/lysosome, SytXIrDN-GFP was found to efficiently localize to lysosomes (Figure 5g) , and overexpression of SytXIrDN-GFP did not affect the repair capability of the astrocytes (Figure 5h ). This suggested that overexpression of Syt XI lacking any Ca 2 + -binding ability does not affect the ability of the endogenous Syt XI to facilitate lysosome exocytosis. Next, to test the ability of Syt XIrDN-GFP to rescue the repair ability of the astrocytes lacking endogenous Syt XI, SytXIrDN-GFP was expressed in cells depleted of endogenous Syt XI (by siRNA2). SytXIrDN-GFP fully rescued the repair defect caused by the lack of endogenous Syt XI (Figure 5i ). This demonstrates that Syt XI regulates astrocyte repair independent of the ability of Ca 2+ binding to its C2 domain.
Discussion
Receptor-mediated [Ca 2+ ] c elevation in astrocytes triggers lysosome exocytosis. 11, 12, 20, 44 We show that astrocyte cell membrane injury causes a greater [Ca 2+ ] c increase, triggering more robust lysosome exocytosis. Receptor stimulation causes a sustained and low rate of exocytosis where lysosomes release a part of their luminal content and none of their membrane proteins (Figures 2 and 6 ). In contrast, cell membrane injury causes a burst of exocytic events where lysosomes release all of their luminal content and deliver their membrane proteins to the cell membrane ( Figures 1,2 (Figures 2 and 3 ). This suggestion is supported by increased partial exocytosis and decreased complete exocytosis of lysosomes when Syt ] c (gray puffs) through calcium influx or efflux from cell exterior or internal stores, respectively. Syt XI (but not Syt VII) facilitates the exocytosis of the lysosomes such that the fusion pore closes rapidly leading to partial release of the luminal content (green) and no mixing of the lysosomal membrane (red) with cell membrane black. (b) Astrocyte injury leading to rupture of the cell membrane (red arrow) causes large influx of extracellular calcium (gray cytosol). Here Syt XI facilitates full fusion of the lysosomes, resulting in complete release of lysosomal luminal content and mixing of the lysosomal membrane with the cell membrane, which allows for the repair of the injured cell membrane VII is expressed on astrocyte lysosomes. We also show that astrocyte lysosomes express Syt XI, which is required for lysosomal exocytosis (Figure 4) . Thus, Syt XI may also facilitate the rapid and complete lysosome exocytosis observed in WT and Syt VII lacking fibroblasts. 29 Our finding that Syt XI localizes to lysosomes and is required for exocytosis of lysosomal membrane protein is in agreement with Syt XI localization to endosome/lysosome in marcophages and its deficit causing reduced delivery of lysosomal membrane proteins to the macrophage cell membrane. 45 Unlike synaptotagmins such as Syt VII, the C2A domains of Syt XI and Syt IV lack calcium and calcium-dependent phospholipid-binding ability in vitro. 46, 47 Despite the lack of Ca 2+ binding by the Syt IV and Syt XI C2A domains, 46 Syt IV facilitates regulated exocytosis in neurons, astrocytes and endocrine cells. 28, [48] [49] [50] Similarly, Syt XI-containing vesicles undergo depolarization-triggered exocytosis in neurons. 42 Similar to neuronal lysosomes, 51 Syt XI-containing exocytic vesicles in neurons are acidic in nature and localize to dendrites. 42 To test whether, similar to Syt IV, the C2B domain of Syt XI helps trigger exocytosis, we mutated the three putative Ca 2+ -binding aspartate (D) residues in the C2B domain of Syt XI to asparagines (N) (SytXIrDN). This mutant protein rescued the knockdown of endogenous Syt XI as efficiently as WT Syt XI, indicating that Syt XI-regulated lysosome exocytosis does not require Ca 2+ binding to C2 domains. A Ca 2+ -independent role attributed to synaptotagmin was illustrated by SytI mutant, which lacks Ca 2+ binding in both its C2 domains and facilitates vesicle docking. 52 
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2+ -independent role of SytI is also supported by its ability to facilitate close membrane apposition in vitro even in the absence of calcium binding [24] [25] [26] and the recent identification of Ca 2+ -independent SNARE-binding motifs. 53 Syt XI may similarly facilitate lysosome docking to the cell membrane. Such a mode of action of Syt XI would recapitulate our recent finding with an unrelated C2 domain containing protein called dysferlin, which facilitated injury-triggered lysosome exocytosis by tethering lysosomes to the cell membrane. 31 As it is the cell membrane proximal lysosome that undergo Ca 2+ -triggered exocytosis, 34 docking lysosome to the cell membrane may be a critical regulatory step for Ca 2+ -triggered lysosomal exocytosis, defect in which compromises cell membrane repair. Another mechanism by which Syt XI may regulate lysosome exocytosis is through interaction with the Q-SNARE Vti1a. 54 Vit1a is known to interact with the lysosomal R-SNARE VAMP7 and regulate spontaneous neurotransmission as well as stimulated secretion. 55, 56 Lysosomal exocytosis facilitates ATP secretion by astrocytes and mechanical injury triggers ATP release from astrocytes. 20, 57 ATP released by astrocytes activates AKT and ERK signaling, resulting in gliosis following traumatic brain injury. 58, 59 Injury-triggered extracellular ATP also affects microglial response following brain injury. 60, 61 We have identified that injury-triggered lysosome exocytosis causes secretion of acid sphingomyelinase (ASM), which is needed for cell membrane repair. 16 ASM secretion by glial cells is also triggered by ATP, which in turn regulates secretion of inflammatory cytokines. 57 Thus, by releasing ASM and ATP in response to injury, lysosome exocytosis can coordinate repair of brain injury at both the cellular and tissue levels. Syt XI could thus be a regulator of the roles attributed to astrocytes in regulation of repair following acute brain injury. 9 Such a role of Syt XI may explain its involvement in neurodegenerative disorders including schizophrenia and Parkinson's. [62] [63] [64] [65] Thus, our findings provide cellular and molecular mechanism for repair of injured astrocytes, and suggest a potential mechanism for the involvement of Syt XI in brain injury repair.
Materials and Methods
Cell culture and transfection. All experiments involving animals were conducted under the Institutional Animal Care and Use Committee (IACUC guidelines). Animals were maintained in a facility accredited by the American Association for Accreditation of Laboratory Animal Care. For primary astrocytes we used a method based on Hertz. 66 Briefly, brain from P0 to P1 pup of C57/Bl6 mouse was removed by decapitation and was immediately put in ice-cold HBSS (without Ca and Mg). Optical bulb, hind brain and meninges were removed under a stereomicroscope (Zeiss stemi 2000, Carl Zeiss Microscopy, LLC, Thornwood, NY, USA) and both the cortical hemispheres minced and digested for 30 min at 37°C in 0.25% Trypsin (GIBCO, Bridgewater, NJ, USA). After 10 triturations, the sample was transferred to pre-warmed Astrocyte Growth Medium (AGM) and cells were collected by centrifugation 1000xg for 5 min. The cell pellet was resuspended in prewarmed AGM and passed through a 70-μm syringe filter to remove lumps. The cell suspension was grown on a 25-cm 2 flask for 5-7 days at 37°C and 5% CO 2 concentration. When the cells were confluent, the flask was shaken overnight at 37°C and 230 r.p.m. (Incushaker Mini, Benchmark, Edison, NJ, USA). Microglia and oligodendrocytes floating in the media were discarded, and the adherent astrocytes were collected with 1 × Trypsin for further use. Astrocytes and HEK293T cells were cultured in DMEM with L-Glutamine and high glucose (PAA, Pasching, Austria), supplemented with fetal bovine serum FBS (PAA; 20% for AGM, 10% for regular media) and with Penicillin/Streptomycin (P/S; PAA). Cells were treated with 10 μM ATP (for purinergic signaling), with 10 μM DHPG (for metabotropic glutamate signaling), or with 10 μM calcium ionophore -ionomycin (for direct calcium increase).
Plasmid transfection and siRNA knockdown. Astrocytes were transfected with plasmids using Lipofectamine 2000 (Life Technologies, Carlsbad, CA, USA) as per the manufacturer's instructions and were allowed express for 48 h. HEK293T cells were transfected with plasmids using Fugene HD (Promega, Madison, WI, USA), and harvested after 48 h. The Syt XI siRNAs used in this study include the following: siRNA 1 (5ʹ-GCACAGUCUGAGCGAGUAC-3ʹ), siRNA2 (5ʹ-AUGUCAAGGUGAACGUCUA-3ʹ), siRNA3 (5ʹ-GAGAGAGGUCUGCGAGAGU-3ʹ) and siRNA4 (5ʹ-CGAUCGCACUACUAAGAAU-3ʹ) and were transfected using Lipofectamine RNAiMAX (Life Technologies)
Immunoblot and immunostaining. Cells grown to 70-80% confluence were lysed with RIPA buffer (Sigma-Aldrich, St. Louis, MO, USA) containing protease inhibitor cocktail (Fisher Scientific, Waltham, MA, USA). Proteins resolved on a 4-12% gradient gel (Life Technologies) were transferred to a nitrocellulose membrane and probed using the following antibodies: Syt VII (1 : 300), Syt XI (1 : 1000; Synaptic Systems, Göttingen, Germany), lysosome-associated membrane protein 1 (LAMP1; 1 : 200; Santa Cruz, Dallas, TX, USA), GAPDH (1 : 1000; Santa Cruz) overnight at 4°C. This was followed by binding for an hour with HRPconjugated appropriate secondary antibody (Sigma-Aldrich) For immunostaining, cells were fixed with chilled methanol and after blocking for 1 h with PBS containing 5% Normal Goat Serum (NGS, Sigma) were probed overnight at 4°C with above primary antibodies: Syt VII (1 : 200), LAMP1 (1 : 300) in blocking solution. Fluorophore-conjugated secondary antibodies (1 : 500) in 5% NGS were incubated for 1 h at room temperature, and nuclei were stained with Hoechst 33342. After mounting in Immunogold mounting medium (Life Technologies) cells were imaged with motorized Olympus FV1000 confocal microscope (×40/1.30 NA oil or × 60/1.40 NA oil or × 100/1.40 NA oil objectives) controlled using the FV10ASW3.0 software (Olympus America, Center Valley, PA, USA).
Lysosome isolation. The cells (packed volume 0.3 ml; 300 million cells) were disrupted in a Dounce homogenizer and the lysate was centrifuged at 1000xg for 10 min and supernatant was centrifuged at 20 000xg for 20 min. The pellet was layered on top of an OptiPrep (Sigma) gradient and centrifuged for 4 h at 4°C at Max-XP Ultracentrifuge. Fractions (~600 μl each; F1-F9) were collected from top to bottom with a fine tipped pipette, protein-estimated and processed for immunoblot. Presence of lysosome was validated with an anti-LAMP1antibody.
Live imaging of lysosomal exocytosis. Cells were subjected to live imaging of cell membrane for injury-triggered lysosome assay as described. 31 Untransfected or astrocytes transfected with Syt VII-CFP were incubated overnight with growth media containing 2 mg/ml of FITC dextran. The cells were washed and incubated for 2 h with growth medium. Cells were then transferred to the microscope stage top ZILCS incubator (Tokai Hit Co, Shizuoka-ken, Japan) maintained at 37°C. For laser injury, cells were imaged with TIRF at the penetration depth of 70-120 nm by imaging at four to six frames/s for 3 min using IX81 Olympus microscope (Olympus America) equipped with × 60/1.45 NA oil objective and 488 nm and Evolve 512 EMCCD (Photometrics, Tucson, AZ, USA) camera, diode laser of 488 nm (Cobolt, Solna, Sweden). Acquisition and analysis was carried out using Slidebook 5.0 and 5.5 (Intelligent Imaging Innovations Inc., Denver, CO, USA).
Cell membrane injury assays. The glass bead injury assay was performed as demonstrated previously. 31 The assay was performed as shown before.
31
Untransfected or Syt VII-transfected, Syt XI knocked down astrocytes cultured on coverslips were transferred to Attofluor cell chamber (Life Technologies), incubated in cell imaging media (CIM) with calcium/PBS buffer with 1 µg/µl FM1-43 dye or 2.5 µg/µl FM4-64 (Life Technologies) and placed on a Tokai Hit microscopy stage top ZILCS incubator (Tokai Hit Co) maintained at 37°C. For laser injury, a 1-2-μm 2 -area was irradiated for o100 ms with a pulsed laser (Ablate!, 3i Intelligent Imaging Innovations Inc. Denver, CO, USA). Cells were imaged at 1-10 s intervals for 5 min using IX81 Olympus microscope (Olympus America) equipped with Lambda DG-4 (Sutter Instruments, Novato, CA, USA) widefield illumination system and Evolve 512 EMCCD (Photometrics) camera, with Cell-TIRFM (Olympus) illuminator and × 60/1.45 NA oil objective using Slidebook 5.0 and 5.5 (Intelligent Imaging Innovations Inc.). Results were expressed as ratio of FM dye intensity over intensity before injury.
Measurement of intracellular calcium. Astrocytes were cultured on glass coverslips and incubated in DMEM with 10 μM of Fluo-4-AM (Life Technologies) for 20 min at 37°C and 5% CO 2 . After washing with pre-warmed cell imaging media (CIM), 31 cells were laser-injured as described previously 31 and imaged at four to eight frames/s. Change in cytosolic Ca 2+ was measured as the ratio change in fluorescence over the background subtracted Fluo-4 fluorescence (ΔF/F0, F0 is Fluo-4 intensity before treatment and ΔF indicates the increase in fluorescence over F0).
Quantification and statistical analysis. The fluorescence intensity of images was quantified using Slidebook 5.0 and 5.5 (Intelligent Imaging Innovations Inc.) or Metamorph7.0 (Molecular Devices, Sunnyvale, CA, USA). The statistical analysis was carried out using the GraphPad Prism Software (GraphPad, LaJolla, CA, USA).
